18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
about
The effect of post-injection 18F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1.Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [(18) F]FDG-PET imaging. Is it of value in asymptomatic patients?Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of 18F-FDG PET.The Role of [18F]FDG-PET/CT in Predicting Malignant Transformation of Plexiform Neurofibromas in Neurofibromatosis-1.Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?Interventional Molecular Imaging.CT, MRI, and 18F-FDG PET/CT findings of malignant peripheral nerve sheath tumor of the head and neck.Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors.
P2860
Q33586072-F8ED4C22-61FF-490F-9ED2-1069F372E5EEQ35961361-8164E19A-4699-437C-B5C9-1A83BB9768EBQ36133106-5D2A6E1A-81C8-4AD8-AEE5-072FD4808945Q38644016-28037CCE-2F43-4B1C-A427-391F31FA6312Q38739306-FC6A0C3F-935D-4E8B-8411-E2E0FED0E3A2Q39037132-0EBAD6FD-FB09-4CF9-A092-353D5E11F25CQ41264048-38562797-6118-4B10-A100-9536BF3C9D65Q47172800-D89A8A43-A2A7-4FA7-9FE1-28859BF66CDBQ51006855-2E1A64C4-FC9B-4C96-90EF-CF065712CF70Q52955813-45E93E78-687D-49AC-ADA9-845BF90BDC99Q52983394-245F552F-B73C-4B4D-9CFC-BDC066313120
P2860
18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
18F-FDG PET/CT qualitative and ...... liver activity normalization.
@en
type
label
18F-FDG PET/CT qualitative and ...... liver activity normalization.
@en
prefLabel
18F-FDG PET/CT qualitative and ...... liver activity normalization.
@en
P2093
P1476
18F-FDG PET/CT qualitative and ...... liver activity normalization.
@en
P2093
Alin Chirindel
Jaishri O Blakeley
Muhammad Chaudhry
Richard Wahl
P304
P356
10.2967/JNUMED.114.142372
P407
P577
2015-02-05T00:00:00Z